
About
AXXAM is a contract research organization that provides early discovery services for the life sciences industry. It works with pharmaceutical, biotechnology, and agrochemical discovery programs from target assessment through hit-to-lead and integrated discovery. It was founded in 2001.
Services
Target assessment
Identifies and evaluates targets using AI-enabled target identification and wet-lab target validation.
AI-enabled target identification
Uses AI-enabled approaches to help identify targets for discovery programs.
Wet-lab target validation
Performs experimental validation of targets in the laboratory.
Biochemical assays
Runs biochemical assay formats for early discovery and screening.
Cell-based assays
Runs cell-based assay formats for target and hit evaluation.
iPSC platform
Uses induced pluripotent stem cell-based models for drug discovery studies.
Electrophysiology
Provides electrophysiology-based assay capabilities.
Organellar electrophysiology
Offers electrophysiology assays focused on organelles.
12 more services
- High content imaging
- Optogenetics
- Bitter taste receptor platform
- Compound management services
- Screening platforms
- Hit identification
- Hit-to-lead discovery
- Exploratory toxicology
- Screening collections
- Integrated drug discovery
- RNA biology
- Agrochemical discovery
Capabilities
- Processes
- Small molecule
- Antibody
- Patch clamp
- High-content imaging
- Cell-based assays
- Biochemical assays
3 more
- Toxicology
- HTS
- Cell-free expression
Equipment
- Automated screening platforms
Materials
- iPSC / organoids
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
Details
- Type
- CRO
- Founded
- 2001
- Based in
- Milan, Italy
- General enquiry
- info@axxam.com on their site